Spyre Therapeutics, Inc.
NASDAQ:SYRE · NASDAQ Capital Market
+$1.21 today
Vol 1.97M · Avg 1.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+501.77%
Period High
$88.34
Period Low
$14.68
Latest
$88.34
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Pharvaris N.V.
NASDAQ:PHVS
$2.33B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.21B
Immunome, Inc.
NASDAQ:IMNM
$1.78B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.77B
Zymeworks Inc.
NASDAQ:ZYME
$1.71B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.68B
Ardelyx, Inc.
NASDAQ:ARDX
$1.45B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.39B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.17B
Upstream Bio, Inc.
NASDAQ:UPB
$339.58M
What is the latest SYRE filing?
The latest filing shown is 8-K dated Jun 15, 2026.
How many recent filings does SYRE have?
Intrinsic Alpha currently shows 20 recent filings for SYRE.
Explore More
Continue the stock analysis
Jump to another research area for this company.